Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers
(1) Lowery FJ (2) Krishna S (3) Yossef R (4) Parikh NB (5) Chatani PD (6) Zacharakis N (7) Parkhurst MR (8) Levin N (9) Sindiri S (10) Sachs A (11) Hitscherich KJ (12) Yu Z (13) Vale NR (14) Lu YC (15) Zheng Z (16) Jia L (17) Gartner JJ (18) Hill VK (19) Copeland AR (20) Nah SK (21) Masi RV (22) Gasmi B (23) Kivitz S (24) Paria BC (25) Florentin M (26) Kim SP (27) Hanada KI (28) Li YF (29) Ngo LT (30) Ray S (31) Shindorf ML (32) Levi ST (33) Shepherd R (34) Toy C (35) Parikh AY (36) Prickett TD (37) Kelly MC (38) Beyer R (39) Goff SL (40) Yang JC (41) Robbins PF (42) Rosenberg SA
Lowery and Krishna et al. combined neoantigen-reactive TCR clonotypes and single-cell transcriptomes to identify shared gene expression profiles (NeoTCR4 and 8) of neoantigen-reactive tumor-infiltrating CD4+ and CD8+ T cells, respectively, from 10 surgically resected metastatic human cancer types. Neoantigen-specific TILs exhibited a dysfunctional phenotype and tumor-specific clonal expansion, with limited overlap in peripheral blood. Over half of TCRs from cells expressing NeoTCR signatures in a test set showed neoantigen and/or tumor reactivity, enabling transcriptomic identification of tumor-reactive TCRs without functional neoantigen screening.
Contributed by Shishir Pant
(1) Lowery FJ (2) Krishna S (3) Yossef R (4) Parikh NB (5) Chatani PD (6) Zacharakis N (7) Parkhurst MR (8) Levin N (9) Sindiri S (10) Sachs A (11) Hitscherich KJ (12) Yu Z (13) Vale NR (14) Lu YC (15) Zheng Z (16) Jia L (17) Gartner JJ (18) Hill VK (19) Copeland AR (20) Nah SK (21) Masi RV (22) Gasmi B (23) Kivitz S (24) Paria BC (25) Florentin M (26) Kim SP (27) Hanada KI (28) Li YF (29) Ngo LT (30) Ray S (31) Shindorf ML (32) Levi ST (33) Shepherd R (34) Toy C (35) Parikh AY (36) Prickett TD (37) Kelly MC (38) Beyer R (39) Goff SL (40) Yang JC (41) Robbins PF (42) Rosenberg SA
Lowery and Krishna et al. combined neoantigen-reactive TCR clonotypes and single-cell transcriptomes to identify shared gene expression profiles (NeoTCR4 and 8) of neoantigen-reactive tumor-infiltrating CD4+ and CD8+ T cells, respectively, from 10 surgically resected metastatic human cancer types. Neoantigen-specific TILs exhibited a dysfunctional phenotype and tumor-specific clonal expansion, with limited overlap in peripheral blood. Over half of TCRs from cells expressing NeoTCR signatures in a test set showed neoantigen and/or tumor reactivity, enabling transcriptomic identification of tumor-reactive TCRs without functional neoantigen screening.
Contributed by Shishir Pant
ABSTRACT: The accurate identification of antitumor T cell receptors (TCRs) represents a major challenge to engineering cell-based cancer immunotherapies. By mapping 55 neoantigen-specific TCR clonotypes (NeoTCRs) from 10 metastatic human tumors to their single-cell transcriptomes, we identified signatures of CD8(+) and CD4(+) neoantigen-reactive tumor-infiltrating lymphocytes (TIL). Neoantigen-specific TIL exhibited tumor-specific expansion with dysfunctional phenotypes, distinct from blood-emigrant bystanders and regulatory TIL. Prospective prediction and testing of 73 NeoTCR signature-derived clonotypes demonstrated that half the tested TCRs recognized tumor antigens or autologous tumors. NeoTCR signatures identified TCRs targeting driver neoantigens and non-mutated viral/tumor-associated antigens, suggesting a common metastatic TIL exhaustion program. NeoTCR signatures delineate the landscape of TIL across metastatic tumors, enabling successful TCR prediction based purely on TIL transcriptomic states for use in cancer immunotherapy.
Author Info:
(1) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (2) Surgery Branch, Center for Cancer Research, N
ational Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (3) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (4) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (5) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (6) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (7) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (8) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (9) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (10) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (11) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (12) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (13) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (14) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (15) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (16) National Institutes of Health Library, National Institutes of Health, Bethesda, MD 20892, USA. (17) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (18) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (19) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (20) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (21) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (22) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (23) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (24) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (25) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (26) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (27) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (28) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (29) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (30) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (31) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (32) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (33) Vector Production Facility, Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Bethesda, MD 20892, USA. (34) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (35) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (36) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (37) Single Cell Analysis Facility, Cancer Research Technology Program, Frederick National Laboratory, Bethesda, MD, 20892, USA. (38) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (39) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (40) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (41) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. (42) Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Citation: Science 2022 Feb 3 eabl5447 Epub02/03/2022
